Home>Topics>Stocks>Holly Energy Partners

Holly Energy Partners HEP

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. UPDATE 1-Australian food company recalls berries after hep A outbreak linked to China

      Headlines

      Mon, 16 Feb 2015

      * Patties says too early to estimate financial impact (Updates with new cases, quote, more cases expected)

    2. Australian food company recalls berries after hep A outbreak linked to China

      Headlines

      Sun, 15 Feb 2015

      SYDNEY, Feb 16 (Reuters) - An Australian company has recalled its frozen berry products following a hepatitis A outbreak linked to poor hygiene and water supplies in a Chinese packaging plant,...

    3. Australia's Patties Foods shares slide after hep A outbreak linked to China

      Headlines

      Sun, 15 Feb 2015

      SYDNEY, Feb 16 (Reuters) - Shares in Australia's Patties Foods Ltd fell as much as 18 percent on Monday after it recalled its frozen berry products following a hepatitis A outbreak that has been...

    4. UPDATE 2-Promising data bodes well for all-Achillion hep C treatment

      Headlines

      Mon, 9 Feb 2015

      * Study shows Achillion's inhibitor looks best-in-class: analyst

    5. Merck's 4Q and Guidance Largely Meet Expectations, but Headwinds Arise For Hep C Drugs and Remicade

      Commentary

      Wed, 4 Feb 2015

      Merck reported fourth-quarter results and issued 2015 guidance largely in line with both our and consensus expectations and we don't expect any changes to our fair value estimate. However, the loss of the FDA's Breakthrough Therapy Designation for Merck's hepatitis C treatment (due to recently ...

    6. UPDATE 1-FDA places Arrowhead Hep B drug on partial hold, shares plunge

      Headlines

      Mon, 12 Jan 2015

      Jan 12 (Reuters) - Drug developer Arrowhead Research Corp said the U.S. Food and Drug Administration placed the company's experimental hepatitis B treatment on partial clinical hold, seeking...

    7. Any thoughts on GILD - Gilliad Sciences

      Commentary

      Mon, 22 Dec 2014

      It has tanked more than 10% this morning on the news that Express Scripts will buy HEp -C drugs from AbbVie only. Is it a good time to add to the current position or dump the shares? Thanks - SAM

    8. UPDATE 1-Achillion data shows promise of shorter-duration hep C treatment

      Headlines

      Mon, 22 Dec 2014

      * Achillion's NS5A inhibitor superior to Gilead's - analysts

    9. Achillion shares soar as potential treatment seen as hep C cure

      Headlines

      Mon, 22 Dec 2014

      Dec 22 (Reuters) - Achillion Pharmaceuticals Inc said it would test a combination of two of its experimental hepatitis C drugs after they showed promise against the virus in separate studies.

    10. HollyFrontier's Shares Undervalued, but Lack of MLP Growth May Prove to Be Headwind

      Commentary

      Thu, 6 Nov 2014

      growth for the firm's more mature master limited partnership, Holly Energy Partners , compared with peers. This issue is unlikely to be resolved soon. Management indicated HEP will grow as it participates in Holly's refining projects, but

    « Prev12345Next »
    Content Partners